Related references
Note: Only part of the references are listed.Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy
Kenneth L. Pitter et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Pan-cancer analysis of whole genomes
Peter J. Campbell et al.
NATURE (2020)
The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists
Carmen Bergom et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
Christopher C. Parker et al.
LANCET (2018)
Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM
Jennifer Ma et al.
ONCOTARGET (2017)
Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients
Christian Nicolaj Andreassen et al.
RADIOTHERAPY AND ONCOLOGY (2016)
Radiation Therapy and Adjuvant Chemotherapy in a Patient With a Malignant Glioneuronal Tumor and Underlying Ataxia Telangiectasia: A Case Report and Review of the Literature
Mariko D. DeWire et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)